GlassScriptPhysician profile
Michael S Sokol
NPI 1235163676
$227,388.10
in general payments reported to CMS, 2019-2025
84 companies · $13K in 2025
The $13K reported for 2025 was more than what 91% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $23K · 2021: $24K · 2022: $70K · 2023: $44K · 2024: $6,874 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Food and Beverage: $11K · Consulting Fee: $8,388 · Travel and Lodging: $5,621 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,250 · Honoraria: $625 · Education: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,356.25 |
| Food and Beverage | $10,625.03 |
| Consulting Fee | $8,387.50 |
| Travel and Lodging | $5,620.91 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,250.00 |
| Honoraria | $625.00 |
| Education | $133.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $85,783.18 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $41,532.57 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $20,727.05 | 2019-2023 | Xarelto |
| Abbott Laboratories | $17,712.46 | 2020-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $13,441.22 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Mannkind Corporation | $11,390.00 | 2019-2025 | Afrezza |
| Nestle Healthcare Nutrition INC. | $9,535.19 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $5,716.49 | 2021-2025 | |
| Clarus Therapeutics INC. | $3,951.63 | 2020-2021 | |
| Amgen INC. | $1,795.03 | 2019-2025 | Evenity, Prolia, Prolia |
| Horizon Therapeutics Plc | $1,703.46 | 2019-2023 | Tepezza |
| Abbvie INC. | $1,542.05 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Aimmune Therapeutics, INC. | $1,376.83 | 2024-2025 | Zenpep |
| Sanofi-Aventis U.S. LLC | $1,017.99 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $1,014.76 | 2020-2025 | Gvoke Hypopen, Recorlev, Keveyis |
Show all 84 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $782.04 | 2019-2025 | |
| Corcept Therapeutics | $679.92 | 2022-2025 | Korlym |
| Chiesi USA, INC. | $641.60 | 2024-2025 | Mycapssa, Myalept |
| Radius Health, INC. | $595.79 | 2019-2025 | Tymlos |
| Amarin Pharma, INC. | $590.90 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.93 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Dexcom, INC. | $339.71 | 2021-2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $310.52 | 2020-2025 | Nexletol, Nexlizet |
| Tandem Diabetes Care, INC. | $310.17 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amneal Pharmaceuticals LLC | $289.52 | 2019-2025 | Unithroid |
| Antares Pharma, INC. | $260.33 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $238.37 | 2019-2023 | Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $231.15 | 2019-2024 | Xifaxan |
| Eisai INC. | $203.02 | 2019-2022 | |
| Beta Bionics, INC. | $181.86 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Currax Pharmaceuticals LLC | $173.29 | 2022-2023 | Contrave, Nexletol, Nexlizet |
| Astellas Pharma US INC | $168.57 | 2022-2025 | Veozah, Myrbetriq |
| Medtronic Minimed, INC. | $163.09 | 2019 | |
| Neurocrine Biosciences, INC. | $154.63 | 2025 | |
| Kyowa Kirin, INC. | $122.16 | 2023-2025 | Crysvita |
| Pharmacosmos Therapeutics INC. | $114.21 | 2024 | Monoferric |
| Axsome Therapeutics, INC. | $110.14 | 2024 | Auvelity |
| Insulet Corporation | $96.14 | 2020-2023 | Omnipod |
| Kowa Pharmaceuticals America, INC. | $95.28 | 2020-2022 | |
| Senseonics, Incorporated | $91.00 | 2020 | |
| Daiichi Sankyo INC. | $88.41 | 2024-2025 | Injectafer |
| Ibsa Pharma INC. | $87.92 | 2019-2025 | Licart, Tirosint, Tirosint |
| Glaxosmithkline, LLC. | $86.90 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Alexion Pharmaceuticals, INC. | $84.93 | 2021-2024 | |
| Recordati_rare_diseases_inc. | $80.46 | 2023-2025 | Isturisa, Signifor Lar |
| Exact Sciences Corporation | $78.04 | 2023-2024 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $72.94 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $72.66 | 2022-2023 | Amvuttra, Onpattro |
| Genzyme Corporation | $72.00 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $70.01 | 2022 | |
| Protega Pharmaceutials INC | $67.29 | 2025 | Roxybond |
| Idorsia Pharmaceuticals US INC | $63.20 | 2022-2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $57.42 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $51.24 | 2019-2021 | |
| Nevro Corp. | $48.31 | 2023 | Senza |
| Ascendis Pharma Endocrinology INC | $46.91 | 2023-2025 | Yorvipath |
| Biogen, INC. | $46.57 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $41.66 | 2019-2023 | |
| Lifescan, INC. | $36.59 | 2022 | |
| Sandoz INC. | $32.80 | 2024 | |
| Medtronic, INC. | $32.64 | 2022 | |
| Amryt Pharma Holdings LTD | $32.50 | 2020-2022 | |
| Allergan, INC. | $32.47 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $30.43 | 2021 | |
| Madrigal Pharmaceuticals | $28.99 | 2025 | Rezdiffra |
| Tolmar, INC. | $28.32 | 2024 | |
| Corium, LLC | $24.85 | 2023 | Adlarity |
| Verity Pharmaceuticals INC. | $24.15 | 2024 | Tlando |
| Zealand Pharma US, INC. | $24.00 | 2021 | |
| Averitas Pharma INC. | $23.72 | 2023 | Qutenza |
| Mdd US Operations, LLC | $23.24 | 2023 | Apokyn |
| Gilead Sciences, INC. | $23.08 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $21.93 | 2023 | Prehevbrio |
| Sumitomo Pharma America, INC. | $21.81 | 2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.14 | 2025 | Caplyta |
| E.R. Squibb & Sons, L.L.C. | $18.25 | 2022 | |
| Boston Scientific Corporation | $18.02 | 2025 | Watchman Flx |
| Cequr Corporation | $15.74 | 2023 | Cequr Simplicity |
| Teva Pharmaceuticals USA, INC. | $14.34 | 2019 | |
| Electromed, INC. | $13.82 | 2025 | Smartvest |
| Nalpropion Pharmaceuticals LLC | $13.24 | 2019 | |
| Vyera Pharmaceuticals, LLC | $11.20 | 2021 | |
| Endogastric Solutions, INC | $7.07 | 2022 | |
| Janssen Scientific Affairs, LLC | $4.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sokol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.